<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-78687</identifier>
<setSpec>0213-005X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci</dc:title>
<dc:description xml:lang="en">The objective of this study was to determine the in vitro activity of daptomycin and other agents against methicillin-resistant Staphylococcus aureus (MRSA) isolates from several sources and coagulase-negative staphylococci (CoNS) from clinically significant blood cultures. Methods We tested a total of 1186 staphylococci isolates (755 MRSA and 431 CoNS) collected as part of a multicenter surveillance program for antimicrobial resistance (VIRA study) from 40 medical centers throughout Spain between 2001 and 2006. Broth microdilution tests were performed according to the Clinical and Laboratory Standards Institute guidelines. Results Most MRSA isolates were resistant to ciprofloxacin (96%) and erythromycin (79.7%). Daptomycin yielded a (..) (AU)</dc:description>
<dc:creator>Picazo, Juan J</dc:creator>
<dc:creator>Gómez,  María</dc:creator>
<dc:creator>Culebras, Esther</dc:creator>
<dc:creator>López, Fátima</dc:creator>
<dc:creator>Rodríguez-Avial, Iciar</dc:creator>
<dc:creator>Betriu, Carmen</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El objetivo de este estudio ha sido evaluar la actividad in vitro de la daptomicina frente a una colección de aislamientos de Staphylococcus aureus resistente a meticilina (SARM) de diversas procedencias y frente a estafilococos coagulasa negativa (ECN) procedentes de hemocultivos clínicamente significativos. Métodos Se incluyeron en el estudio un total de 1.186 cepas de estafilococos (755 SARM y 431 ECN) procedentes de 40 hospitales españoles integrados en el programa VIRA (Vigilancia de Resistencias a los Antimicrobianos) correspondientes al período 2001 al 2006. Los estudios de sensibilidad se llevaron a cabo mediante el método de microdilución en caldo. Resultados La mayor parte de los aislamientos de SARM fueron resistentes al ciprofloxacino (96%) y a la eritromicina (79,7%). Los valores de concentración inhibitoria mínima frente al 50 y al 90% de las cepas de daptomicina fueron (..)  (AU)</dc:description>
<dc:source>Enferm Infecc Microbiol Clin;28(1): 13-16, ene. 2010. tab</dc:source>
<dc:identifier>ibc-78687</dc:identifier>
<dc:title xml:lang="es">Actividad comparativa de la daptomicina frente a Staphylococcus aureus resistente a meticilina y frente a estafilococos coagulasa negativa</dc:title>
<dc:subject>^d31518^s22078</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d13595^s22026</dc:subject>
<dc:subject>^d13595^s22021</dc:subject>
<dc:subject>^d24244</dc:subject>
<dc:subject>^d29045</dc:subject>
<dc:subject>^d13590^s22046</dc:subject>
<dc:subject>^d13595^s22001</dc:subject>
<dc:subject>^d22780</dc:subject>
<dc:subject>^d13595^s22011</dc:subject>
<dc:type>article</dc:type>
<dc:date>201001</dc:date>
</metadata>
</record>
</ibecs-document>
